whole genome oligonucleotide 4 180k isca v2 microarray chip Search Results


custom designed 4 × 180k oligonucleotide microarray  (Oxford Gene Technology)
86
Oxford Gene Technology custom designed 4 × 180k oligonucleotide microarray
Custom Designed 4 × 180k Oligonucleotide Microarray, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/60k+cytosure+constitutional+v3+microarray/pmc06028426-12-51-58
Average 86 stars, based on 1 article reviews
custom designed 4 × 180k oligonucleotide microarray - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
4 × 180 k custom oligonucleotide microarray  (Oxford Gene Technology)
90
Oxford Gene Technology 4 × 180 k custom oligonucleotide microarray
4 × 180 K Custom Oligonucleotide Microarray, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/180+k+oligonucleotide+microarray/pmc10100507-65-5-22
Average 90 stars, based on 1 article reviews
4 × 180 k custom oligonucleotide microarray - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
4 × 180 k cytosureisca v2 oligonucleotide microarray platform  (Oxford Gene Technology)
90
Oxford Gene Technology 4 × 180 k cytosureisca v2 oligonucleotide microarray platform
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
4 × 180 K Cytosureisca V2 Oligonucleotide Microarray Platform, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/4+%C3%97+180+k+cytosureisca+v2+oligonucleotide+microarray+platform/pmc05865210-168-9-14
Average 90 stars, based on 1 article reviews
4 × 180 k cytosureisca v2 oligonucleotide microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
4×180k wholegenome oligonucleotide microarray  (WholeGenome LLC)
90
WholeGenome LLC 4×180k wholegenome oligonucleotide microarray
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
4×180k Wholegenome Oligonucleotide Microarray, supplied by WholeGenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/4%C3%97180k+wholegenome+oligonucleotide+microarray/pm36849228-44-23-24
Average 90 stars, based on 1 article reviews
4×180k wholegenome oligonucleotide microarray - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
oligonucleotide array cytochip v1.0 180k  (BlueGnome Limited)
90
BlueGnome Limited oligonucleotide array cytochip v1.0 180k
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
Oligonucleotide Array Cytochip V1.0 180k, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/cytochip+oligo+array/pmc04411736-110-9-14
Average 90 stars, based on 1 article reviews
oligonucleotide array cytochip v1.0 180k - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
oligonucleotide microarray platforms cytochip oligo 8 × 60 k  (BlueGnome Limited)
90
BlueGnome Limited oligonucleotide microarray platforms cytochip oligo 8 × 60 k
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
Oligonucleotide Microarray Platforms Cytochip Oligo 8 × 60 K, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/oligonucleotide+microarray+platforms+cytochip+oligo+8+%C3%97+60+k/pmc09621608-51-31-69
Average 90 stars, based on 1 article reviews
oligonucleotide microarray platforms cytochip oligo 8 × 60 k - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cytosure syndrome plus v2 oligonucleotide array  (Oxford Gene Technology)
90
Oxford Gene Technology cytosure syndrome plus v2 oligonucleotide array
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
Cytosure Syndrome Plus V2 Oligonucleotide Array, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/105k+oligonucleotide+microarray+cytosure+syndrome+plus+v2/pmc03589530-76-22-28
Average 90 stars, based on 1 article reviews
cytosure syndrome plus v2 oligonucleotide array - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray v3 105k oligo  (GenomeDx Inc)
90
GenomeDx Inc microarray v3 105k oligo
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
Microarray V3 105k Oligo, supplied by GenomeDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/microarray+v3+105k+oligo/pm22847950-280-69-73
Average 90 stars, based on 1 article reviews
microarray v3 105k oligo - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dna microarray capitalbio human lncrna array v4  (CapitalBio Corporation)
90
CapitalBio Corporation dna microarray capitalbio human lncrna array v4
Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal <t>microarray</t> analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
Dna Microarray Capitalbio Human Lncrna Array V4, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+genome+oligonucleotide+4+180k+isca+v2+microarray+chip/human+lncrna+array+v4/pmc06487373__mmc1-55-2-4
Average 90 stars, based on 1 article reviews
dna microarray capitalbio human lncrna array v4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal microarray analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included

Journal: European Journal of Human Genetics

Article Title: Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray

doi: 10.1038/s41431-017-0020-3

Figure Lengend Snippet: Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal microarray analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included

Article Snippet: CMA was undertaken using the 4 × 180 K CytoSureISCA v2 oligonucleotide microarray platform (Oxford Gene Technology, Oxford, UK), the standard diagnostic service offered by SickKids Clinical Laboratory Improvement Amendments (CLIA)-certified diagnostic laboratory.

Techniques: Diagnostic Assay, Microarray, Sequencing, Activity Assay, Biomarker Discovery